Rx Roundup: Quiz of the Week — May 10, 2024

Quiz
Article

Test your pharmacy news knowledge with our weekly quiz.

Did you get your fill of pharmacy news this week? Take the Rx Roundup quiz of the week and test your knowledge about the latest stories published by the Drug Topics team from May 6 to May 10.

The SOLARIS clinical trial evaluated TEV-749, a once-monthly, subcutaneous, long-acting injectable form of what antipsychotic medication?


Recent Videos
Related Content
DOJ Lawsuit Alleges CVS Helped Fuel Opioid Epidemic Through Unlawful Opioid Prescriptions

DOJ Lawsuit Alleges CVS Helped Fuel Opioid Epidemic Through Unlawful Opioid Prescriptions

Lauren Biscaldi, MS, Managing Editor
December 19th 2024
Article

The lawsuit alleges that the company knowingly violated both the Controlled Substances Act and the False Claims Act.

Tapinarof Cream 1% Approved by FDA to Treat Atopic Dermatitis in Adults, Children 2 Years and Older

Tapinarof Cream 1% Approved by FDA to Treat Atopic Dermatitis in Adults, Children 2 Years and Older

Killian Meara
December 16th 2024
Article

Vtama from Organon was previously approved in May 2022 to treat plaque psoriasis in adults.

Psychiatric Pharmacist Working to Optimize Treatment, Improve Patient Safety

Psychiatric Pharmacist Working to Optimize Treatment, Improve Patient Safety

Killian Meara;Nina Vadiei, PharmD, BCPP
December 13th 2024
Article

A conversation with Nina Vadiei, PharmD, BCPP, clinical associate professor in the Division of Pharmacotherapy at University of Texas at Austin College of Pharmacy and a clinical pharmacy specialist in psychiatry at the San Antonio State Hospital.

Q&A: Pharmacist Discusses Unique Challenges in Psychiatric Population

Q&A: Pharmacist Discusses Unique Challenges in Psychiatric Population

Killian Meara
December 12th 2024
Article

Nina Vadiei, PharmD, BCPP, discusses some of the challenges she faces working with forensic patients who have been charged with a crime and have severe mental illness.

AMA Urges Policymakers to Act Despite Report of Improved Opioid Epidemic

AMA Urges Policymakers to Act Despite Report of Improved Opioid Epidemic

Brian Nowosielski
December 4th 2024
Article

AMA released its 2024 Overdose Epidemic Report and presented key findings from the past year.

Drug Review: Lebrikizumab-lbkz Demonstrates Improvement in Atopic Dermatitis

Drug Review: Lebrikizumab-lbkz Demonstrates Improvement in Atopic Dermatitis

Allison Ketterer, PharmD Candidate
November 25th 2024
Article

FDA approval was granted on September 13, 2024.

© 2024 MJH Life Sciences

All rights reserved.